AI Mood Market: Stock Dashboard

Company: Anavex Life Sciences Corporation

Sector: Healthcare

Industry: Biotechnology

Country: USA

Exchange: NASD

Index: RUT

P/E: -

EPS (ttm): -0.57

Insider Own: 3.40%

Shs Outstand: 85.41M

Perf Week: -9.30%

Market Cap: 569.47M

Forward P/E: 4.71

EPS next Y: 1.41

Insider Trans: 0.00%

Shs Float: 82.98M

Perf Month: -24.62%

Enterprise Value: 468.31M

PEG: -

EPS next Q: -0.15

Inst Own: 38.23%

Short Float: 32.13%

Perf Quarter: -34.42%

Income: -48.17M

P/S: -

EPS this Y: -11.19%

Inst Trans: 1.59%

Short Ratio: 21.55

Perf Half Y: -18.85%

Sales: 0.00M

P/B: 6.23

EPS next Y Percentage: 343.69%

ROA: -39.47%

Short Interest: 26.66M

Perf YTD: -38.27%

Book/sh: 1.06

P/C: 5.63

EPS next 5Y: -

ROE: -43.63%

52W High: 14.44 -54.09%

Perf Year: -28.25%

Cash/sh: 1.18

P/FCF: -

EPS past 3/5Y: 1.74% 0.85%

ROIC: -52.96%

52W Low: 6.35 4.41%

Perf 3Y: -42.30%

Dividend Est.: -

EV/EBITDA: -

Sales past 3/5Y: - -

Gross Margin: -

Volatility W: 8.25%

Volatility M: 6.15%

Perf 5Y: -12.53%

Dividend TTM: -

EV/Sales: -

EPS Y/Y TTM: -13.05%

Oper. Margin: -

ATR (14): 0.49

Perf 10Y: -50.15%

Dividend Ex-Date: -

Quick Ratio: 8.93

Sales Y/Y TTM: -

Profit Margin: -

RSI (14): 27.39

Recom: 1.67

Dividend Gr. 3/5Y: - -

Current Ratio: 8.93

EPS Q/Q: -7.34%

SMA20: -17.74%

Beta: 1.12

Target Price: 44.00

Payout: -

Debt/Eq: 0.00

Sales Q/Q: -

SMA50: -23.67%

Rel Volume: 1.28

Prev Close: 6.85

Employees: 42

LT Debt/Eq: 0.00

Earnings: Aug 12 BMO

SMA200: -27.26%

Avg Volume: 1.24M

Price: 6.63

IPO: Aug 02, 2006

Option/Short: Yes / Yes

EPS/Sales Surpr.: -12.44% -

Trades:

Volume: 822,136

Change: -3.21%

AI Market Mood: Stock Dashboard

AVXL

Fundamental

Technical:

Latest News:

Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference neutral

ANVS AVXL LGVN